1. Nature Japan
  2. Nature Biotechnology
  3. v34 n4
  4. データ共有の設計から始めよ
Opinion and Comment

データ共有の設計から始めよ

Nature Biotechnology 34, 4 doi: 10.1038/nbt.3516

To upend current barriers to sharing clinical data and insights, we need a framework that not only accounts for choices made by trial participants but also qualifies researchers wishing to access and analyze the data.
Full text
PDF

目次へ戻る

advertisement
プライバシーマーク制度